Publications by John Petkau
2004
. A case-crossover analysis of particulate air pollution and cardiac arrhythmia in patients with implantable cardioverter defibrillators. Inhalation Toxicology. Taylor & Francis; 2004;16:363–372.
. Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing/remitting multiple sclerosis. Multiple Sclerosis. 2004;10:715.
2003
. Statistical approaches to assessing the effects of neutralizing antibodies IFNβ-1b in the pivotal trial of relapsing-remitting multiple sclerosis. Neurology. AAN Enterprises; 2003;61:Supplement 5:S35–S37.
. Neutralising antibodies to interferon beta during the treatment of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry. 2003;74:1162.
. Neutralising antibodies during treatment of secondary progressive multiple sclerosis with interferon beta-1b. Neurology. 2003;61:1025.
. Neutralizing antibodies during treatment of secondary progressive multiple sclerosis with interferon β-1b. Neurology. AAN Enterprises; 2003;60:37–43.
. Air pollution and daily mortality in a city with low levels of pollution. Environmental Health Perspectives. National Institute of Environmental Health Science; 2003;111:45-51.
. Optimal group sequential designs for the Anscombe-Colton model. In Mathematical Statistics and Applications: Festschrift for Constance van Eeden. IMS Lecture Notes - Monograph Series; 2003. pp. 291–315.
2002
. Exposure misclassification and threshold concentrations in time series analyses of air pollution health effects. Risk Analysis. Wiley Online Library; 2002;22:1183–1193.
2001
. Exposure of chronic obstructive pulmonary disease patients to particles: Respiratory and cardiovascular health effects. Journal of Exposure Analysis and Environmental Epidemiology. 2001;11:490-500.
2000
. Exposure of chronic obstructive pulmonary disease patients to particulate matter: Relationships between personal and ambient air concentrations. Journal of the Air and Waste Management Association. Taylor & Francis; 2000;50:1081–1094.
. Impact of antibodies to interferon-β during treatment of multiple sclerosis. In Drug Treatment of Multiple Sclerosis. Auckland: Adis International; 2000. pp. 89–108.
1999
. Natural killer cells in relapsing-remitting multiple sclerosis: the effect of treatment with interferon β-1B. Neurology. AAN Enterprises; 1999;52:351–359.
. Neutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?. CNS Drugs. Springer; 1999;11:225–243.
. Lesion load reproducibility and statistical sensitivity of clinical trials in multiple sclerosis. Neurology. 1999;52:433-434.
. Development of a multiple sclerosis functional composite as a clinical trials outcome measure. Brain. Oxford Univ Press; 1999;122:871–882.
. Nonparametric two-sample comparisons of changes on ordinal responses. Journal of the American Statistical Association. Taylor & Francis; 1999;94:970–978.
1998
. Acute effects of ambient inhalable particles in asthmatic and nonasthmatic children. American Journal of Respiratory and Critical Care Medicine. Am Thoracic Soc; 1998;157:1034–1043.
. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. Journal of Neuroimmunology. Elsevier; 1998;86:123–133.
. Statistical methods for evaluating multiple sclerosis therapies. Seminars in Neurology. 1998;18:351–375.
1997
. Longitudinal analyses for magnetic resonance imaging outcomes in multiple sclerosis clinical trials. Journal of Biopharmaceutical Statistics. Taylor & Francis; 1997;7:501–531.
. Recommendations from the National Multiple Sclerosis Society clinical outcomes assessment task force. Annals of Neurology. Wiley Online Library; 1997;42:379–382.
1996
. Surveillance of clustering near point sources. Statistics in Medicine. Wiley Online Library; 1996;15:727–740.
. Statistical and design considerations for multiple sclerosis clinical trials. In Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives. London: Springer-Verlag; 1996. pp. 63–103.
. Clinical outcomes assessment in multiple sclerosis. Annals of Neurology. Wiley Online Library; 1996;40:469–479.
1995
. A likelihood ratio test for equality of deviations from randomness. Researches on Population Ecology. Springer; 1995;37:203–209.
1994
. Spatial association learning in hummingbirds. In Case Studies in Biometry. New York: John Wiley & Sons; 1994. pp. 159-187.
. Overdispersed Poisson regression models for studies of air pollution and human health. Canadian Journal of Statistics. Wiley Online Library; 1994;22:421–440.
1993
. Magnetic resonance imaging (MRI) as an outcome measure in multiple sclerosis. Journal of Neurological Rehabilitation. SAGE Publications; 1993;7:117–129.
1990
. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology. AAN Enterprises; 1990;40:479–486.
. A regression model with random effects for beer chemistry and Canadians' beer preferences. Canadian Journal of Statistics. Wiley Online Library; 1990;18:108–121.
1989
. The effect of truncation on a sequential test for the drift of Brownian motion. Sequential Analysis. Taylor & Francis; 1989;8:169–190.
. Models for quantal response experiments over time. Biometrics. JSTOR; 1989;45:1299–1308.
1988
. The variability of rainfall acidity revisited. Canadian Journal of Statistics. JSTOR; 1988;16:15–38.
. Objective criteria for in-vitro responses in human tumor colony-forming assays. Medical Decision Making. SAGE Publications; 1988;8:304–309.
1987
. Truncated sequential medical trials involving paired data. Canadian Journal of Statistics. Wiley Online Library; 1987;15:363–374.
1986
. Numerical solutions for Bayes sequential decision problems. SIAM Journal on Scientific and Statistical Computing. SIAM; 1986;7:46–59.
1985
. Thiopental requirements may be increased in children re-anesthetized at least one year after recovery from extensive thermal injury. Anesthesia and Analgesia. LWW; 1985;64:1156–1160.
. Sequential medical trials with ethical cost. In Proceedings of the Berkeley Conference in Honor of Jerzy Neyman and Jack Kiefer. Monterey: Wadsworth; 1985. pp. 521-538.
1984
. Relative efficiencies of goodness-of-fit procedures with truncated data. Canadian Journal of Statistics. Wiley Online Library; 1984;12:107–117.
1983
. Effects of leukotrienes B4 and C4 on coronary circulation and myocardial contractility. Surgery. 1983;94:267–275.
. Wasted ventilation measured in vitro with eight anesthetic circuits with and without inline humidification. Anesthesiology. 1983;59:442–446.
1982
. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science. American Association for the Advancement of Science; 1982;217:841–843.
. Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease. Journal of Clinical Endocrinology and Metabolism. The Endocrine Society; 1982;55:1100–1107.
1981
. Sequential medical trials involving paired data. Biometrika. Biometrika Trust; 1981;68:119–132.
. Comparison of procedures for testing the equality of two survival distributions. Biometrics. JSTOR; 1981;37:327–340.
. A comparison of n-estimators for the binomial distribution. Journal of the American Statistical Association. Taylor & Francis; 1981;76:637–642.
1980
. Frequentist properties of three stopping rules for comparative clinical trials. Biometrika. Biometrika Trust; 1980;67:690–692.
1979
. An application of dynamic programming in statistics. In Dynamic Programming and its Applications. New York: Academic Press; 1979. pp. 221-232.
. A satellite control problem. In Oprimizing Methods in Statistics. New York: Academic Press; 1979. pp. 89-124.